Announcements Trials
Browse Landscape

Status

Completed 13Unknown 7Recruiting 4Withdrawn 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 21Observational 4

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 123Surveys and Questionnaires 82Observation 49Radiotherapy 40Surgical Procedures, Operative 34Drug Therapy 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 20Interviews as Topic 20Magnetic Resonance Imaging 18Immune Checkpoint Inhibitors 17Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Neoadjuvant Therapy 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Observational × Chemotherapy, Adjuvant × Clear all
NCT05595408 2025-12-09

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma

RenJi Hospital

Recruiting
84 enrolled
Tumor-Agnostic

Neoplasm, Residual

NCT06476119 2025-04-23

OPTImaL

The Netherlands Cancer Institute

Recruiting
490 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06792149 2025-01-24

Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting

Peking Union Medical College Hospital

Recruiting
60 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04902937 2023-11-28

CETC

University of Jena

Recruiting
200 enrolled

Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡